SqueezeFinder1 Posted - 18 hours ago

Here are some tickers to keep on your radar going forward, and their respective confidence levels ranging from 1-3 🍊. (Please note that confidence levels are subjective to personal observation and strategy, and should be reviewed individually prior to assuming success potential) 1. $TBLT Squeezability Score: 84% Juice Target: 9.0 Confidence: 🍊 🍊 🍊 Major Support: 4.5 Major Resistance: 6.0 Mentions (30D): 2 Event: No scheduled events. 2. $AVXL Squeezability Score: 62% Juice Target: 8.6 Confidence: 🍊 🍊 Major Support: 6.0 Major Resistance: 7.0 Mentions (30D): 7 Event: No scheduled events. 3. $IMNM Squeezability Score: 59% Juice Target: 30 Confidence: 🍊 🍊 🍊 Major Support: 14.85 Major Resistance: 16.8 Mentions (30D): 0 Event: No scheduled events. Check my profile for more ideas and daily alerts :)

vikingforthewin Posted - 1 day ago

$IMNM call his puts to be a billionaire

Vic05 Posted - 1 day ago

$IMNM The squeeze will be epic!!!

briefingcom Posted - 1 day ago

$IMNM: Immunome provides an update on recent business development activity, including three recently closed transactions that are expected to enhance the company’s antibody-drug conjugate capabilities https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20240725080712IMNM&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page

Vic05 Posted - 1 day ago

$IMNM Almost a quarter of the float is short

DonCorleone77 Posted - 1 day ago

$IMNM Immunome provides update, sees recent transactions improving ADC capabilities Immunome provided an update on recent business development activity, including three recently closed transactions that are expected to enhance the company's antibody-drug conjugate or ADC capabilities. Immunome acquired worldwide, exclusive rights to: A panel of antibodies against an undisclosed solid tumor target from Nectin Therapeutics; A panel of antibodies against an undisclosed solid tumor target from Bluefin Biomedicine; Four antibodies against undisclosed targets from OncoResponse; In addition, the company previously announced the purchase of 28 antibodies from Atreca in May 2024 and the exclusive license of IM-1021 along with the underlying ADC platform technology from Zentalis in January 2024. None of the acquired antibodies are known to share the same target as an FDA approved ADC. "Immunome's long-term vision remains centered on a broad pipeline of targeted therapies, particularly ADCs against novel targets," said Clay Siegall, PhD, President and Chief Executive Officer of Immunome. "Focused business development activity complements our highly productive internal discovery efforts and has led to an advancing pipeline of product candidates."

Stock_Titan Posted - 1 day ago

$IMNM Immunome Provides Update on Recent Business Development Activity Expected to Expand ADC Capabilities https://www.stocktitan.net/news/IMNM/immunome-provides-update-on-recent-business-development-activity-ox9slsz6gh45.html

Stock_Titan Posted - 1 day ago

$IMNM Nectin Therapeutics Licenses Novel Antibodies to Immunome https://www.stocktitan.net/news/IMNM/nectin-therapeutics-licenses-novel-antibodies-to-omkdw137usxi.html

vikingforthewin Posted - 1 day ago

$IMNM you model always sucks

intratio Posted - 2 days ago

$IMNM https://www.intratio.com/stock-forecast/IMNM Immunome Inc. Our model has predicted the stock price of this company has a clearly poor short-term setup and will have a very negative trend in the upcoming months

Vic05 Posted - 4 days ago

$IMNM Some 2 million share days like we had in February and this explodes

Jeff9905 Posted - 1 week ago

$IMNM another job posting. Basic brick and mortar lab tech job. Great sign something is up.

vikingforthewin Posted - 1 week ago

$IMNM blowing up soon guys

Elliotwavedave Posted - 2 weeks ago

$IMNM it’s still cheap penny flippers. Think twice before you sell and buy your Tito’s at Costco.

vikingforthewin Posted - 2 weeks ago

$IMNM $IWM

Elliotwavedave Posted - 2 weeks ago

$IMNM stay away bots!!

Jeff9905 Posted - 2 weeks ago

$IMNM yep. 6 more job postings . 7/10

Snozz Posted - 2 weeks ago

$IMNM Their CTO is posting on LinkedIn that they are looking for people. The fact that these are CMC roles is very indicative of how they see things progressing. Clinical stage pharm shops looking for CMC talent is a very significant leading indicator.

Jeff9905 Posted - 2 weeks ago

$IMNM lots of hiring (postings anyway) and stock inching up on low volume. Very similar to early Seagen. Just saying.

Jeff9905 Posted - 2 weeks ago

$IMNM 3 more job postings today. Anyone know if they are actually filling these openings?

vikingforthewin Posted - 2 weeks ago

$IMNM Clay won’t let us down, long term investment guys🤓

Jeff9905 Posted - 3 weeks ago

$IMNM another dump at close. Company needs to do something other than siphon off sucker's money.

Raging_Bull777 Posted - 3 weeks ago

$IMNM The co-founder and CEO of SGEN is now the CEO of IMNM. Clay Siegall CEO and CMO Bob Lechleider both lead Seattle Genetics (renamed to Seagen) to be acquired by Pfizer. Solid leadership team with great pipeline. Rinse and Repeat!

vikingforthewin Posted - 3 weeks ago

$IMNM will go much higher starting from today

Jeff9905 Posted - 3 weeks ago

$IMNM when is the supposed Clay effect gonna effect.

Fast_Eddie_Felson Posted - 3 weeks ago

$IMNM from 30 to junk quickly

SeekingOctane Posted - 3 weeks ago

$GILD $IMNM $VINC

SeekingOctane Posted - 06/30/24

$VINC Data Tracking well similar to Trodelvy’s (Same chemo warhead SN38) Phase 1, and that spurred $GILD to buy Immunomedics for $21 billion. $IMNM

Durand32 Posted - 06/28/24

$IMNM I'm in Thailand and just woke up and see 8.6 million shares traded today and the share price barely moved. WTF is going on

SeekingOctane Posted - 06/28/24

$IMNM Selling about done - I think it came from Ayala Advaxis leak out.